Gilead Science reports positive data in trial of remdesivir as treatment for COVID-19
April 29, 2020 at 09:41 AM EDT
Gilead Sciences Inc. said that its experimental COVID-19 therapy remdesivir met the main goal in a government-funded clinical trial and that a shorter dosing regimen was as successful as a longer one in a separate study.
